Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03008694
Recruitment Status : Unknown
Verified December 2016 by yahua zhong, Zhongnan Hospital.
Recruitment status was:  Not yet recruiting
First Posted : January 2, 2017
Last Update Posted : January 2, 2017
Sponsor:
Information provided by (Responsible Party):
yahua zhong, Zhongnan Hospital

Brief Summary:
This study evaluates the effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in oral Cancer patients. Progress-free survival (PFS) will be compared with historical control as defined in the protocol

Condition or disease Intervention/treatment Phase
Oral Cancer Radiotherapy; Complications Device: PET/CT Phase 2

Detailed Description:
Radiotherapy improves local control and overall survival for oral cavity cancer patients after surgery. However, limited locoregional control remains a key issue in the management of oral cavity carcinomas. Appropriate target selection is a key issue in the radiotherapy of oral cavity cancer. The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of oral cancer

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phrase II Single Arm Study of Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral
Study Start Date : January 2017
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : January 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Oral Cancer

Arm Intervention/treatment
Experimental: 1
PET/CT
Device: PET/CT
pet/ct is used as radiotherapy simulation




Primary Outcome Measures :
  1. progress free survival [ Time Frame: baseline to 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Histologically confirmed oral squamous-cell carcinoma
  • Age > 17 years
  • Signed informed consent
  • ECOG Performance status 0-2
  • Must be able to start RT within 4 weeks after PET/CT simulation

Exclusion Criteria:

  • stage IV disease diagnosed before acquisition of staging PET/CT
  • prior radiotherapy to oral and neck
  • Unable to understand study participation
  • Claustrophobia
  • pregnant or breast feeding mothers

Layout table for additonal information
Responsible Party: yahua zhong, Director,oncology , Principal Investigator, Clinical Professor, Zhongnan Hospital
ClinicalTrials.gov Identifier: NCT03008694     History of Changes
Other Study ID Numbers: ZhongnanH
First Posted: January 2, 2017    Key Record Dates
Last Update Posted: January 2, 2017
Last Verified: December 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Keywords provided by yahua zhong, Zhongnan Hospital:
PET/CT
Additional relevant MeSH terms:
Layout table for MeSH terms
Mouth Neoplasms
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms
Mouth Diseases
Stomatognathic Diseases